Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib

Niesor, EJ; Boivin, G; Rheaume, E; Shi, R; Lavoie, V; Goyette, N; Picard, ME; Perez, A; Laghrissi-Thode, F; Tardif, JC

Tardif, JC (corresponding author), Univ Montreal, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.; Niesor, EJ (corresponding author), DalCor Pharmaceut, Montreal, PQ H3A 2R7, Canada.

ACS OMEGA, 2021; 6 (25): 16584

Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction......

Full Text Link